pH/Redox Dual-Responsive Polyplex with Effective Endosomal Escape for Codelivery of siRNA and Doxorubicin against Drug-Resistant Cancer Cells
Source abstract
Abstract
The enhanced endo-lysosomal sequestration still remains a big challenge in overcoming multidrug resistance (MDR). Herein, a dual-responsive polyplex with effective endo-lysosomal escape based on methoxypoly(ethylene glycol)-polylactide-polyhistidine-ss-oligoethylenimine (mPEG- b-PLA-PHis-ssOEI) was developed for codelivering MDR1 siRNA and doxorubicin (DOX). The polyplex showed good encapsulation of DOX and siRNA as well as triggered payload release in response to pH/redox stimuli because of the PHis protonation and the disulfide bond cleavage. The polyplex at an N/P ratio of 7 demonstrated a much higher payload delivery efficiency, MDR1 gene silence efficiency, cytotoxicity against MCF-7/ADR cell, and stronger MCF-7/ADR tumor growth inhibition than the polyplexes at higher N/P ratios. This was attributed to the stronger electrostatic attraction between siRNA and OEIs at higher N/P ratios that suppressed the release of MDR1 siRNA and OEIs, which played a dominant role in overcoming payload endo-lysosomal sequestration by the OEI-induced membrane permeabilization effect. Consequently, the polyplex with effective endo-lysosomal escape provides a rational approach for codelivery of siRNAs and chemotherapy agents for MDR reversal.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · DNA and Nucleic Acid Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacy, Heze Medical College, Heze 274000, P. R. China
Funding
National Natural Science Foundation of China · Career Development Support Plan for Young and Middle-aged Teachers in Shenyang Pharmaceutical University
References (61)
Show source-provided references
1. 10.1016/j.addr.2013.08.00610.1016/j.addr.2013.08.006 ↗
2. 10.1016/j.addr.2013.09.01910.1016/j.addr.2013.09.019 ↗
3. 10.1016/j.addr.2013.09.01710.1016/j.addr.2013.09.017 ↗
4. 10.1016/j.mattod.2014.05.00210.1016/j.mattod.2014.05.002 ↗
5. Nourbakhsh M. · Iran. J. Basic Med. Sci. · 2015 · 18 · 385
6. 10.1016/j.ijpharm.2017.09.06010.1016/j.ijpharm.2017.09.060 ↗
7. 10.1021/acsami.5b1178910.1021/acsami.5b11789 ↗
8. 10.1002/adfm.20170308310.1002/adfm.201703083 ↗
9. 10.1016/j.colsurfb.2017.06.00210.1016/j.colsurfb.2017.06.002 ↗
10. 10.1021/nn103349h10.1021/nn103349h ↗
11. 10.2174/13892011280062441810.2174/138920112800624418 ↗
12. 10.1080/17425247.2016.120558310.1080/17425247.2016.1205583 ↗
13. 10.1021/acs.molpharmaceut.8b0003110.1021/acs.molpharmaceut.8b00031 ↗
14. 10.1016/j.biomaterials.2011.10.05710.1016/j.biomaterials.2011.10.057 ↗
15. 10.1016/j.drudis.2016.06.02910.1016/j.drudis.2016.06.029 ↗
16. 10.1016/j.canlet.2015.10.01010.1016/j.canlet.2015.10.010 ↗
17. 10.2174/1568009611313999007610.2174/15680096113139990076 ↗
18. 10.2217/nnm.11.9310.2217/nnm.11.93 ↗
19. 10.1016/j.ejpb.2019.01.00610.1016/j.ejpb.2019.01.006 ↗
20. 10.1016/j.biomaterials.2014.06.03510.1016/j.biomaterials.2014.06.035 ↗
21. 10.1016/j.biomaterials.2013.01.05310.1016/j.biomaterials.2013.01.053 ↗
22. 10.1021/acsami.8b1339310.1021/acsami.8b13393 ↗
23. 10.1021/acs.biomac.8b0027210.1021/acs.biomac.8b00272 ↗
24. 10.1021/mp100460h10.1021/mp100460h ↗
25. 10.1016/j.biomaterials.2018.01.04210.1016/j.biomaterials.2018.01.042 ↗
26. 10.1007/s12551-017-0341-z10.1007/s12551-017-0341-z ↗
27. 10.1021/nn201370710.1021/nn2013707 ↗
28. 10.1016/j.addr.2013.04.01110.1016/j.addr.2013.04.011 ↗
29. 10.1021/mp900225510.1021/mp9002255 ↗
30. 10.1002/anie.20140727210.1002/anie.201407272 ↗
31. 10.1039/c5py00034c10.1039/c5py00034c ↗
32. 10.1038/srep2385910.1038/srep23859 ↗
33. 10.1002/smll.20130395110.1002/smll.201303951 ↗
34. 10.1038/nbt.261210.1038/nbt.2612 ↗
35. 10.1038/nbt.329810.1038/nbt.3298 ↗
36. 10.1039/c4nr00018h10.1039/c4nr00018h ↗
37. 10.1021/acs.nanolett.8b0255310.1021/acs.nanolett.8b02553 ↗
38. 10.1021/mp400787s10.1021/mp400787s ↗
39. 10.1038/bjc.1987.28210.1038/bjc.1987.282 ↗
40. 10.1021/mp500024p10.1021/mp500024p ↗
41. 10.1093/jnci/78.1.17110.1093/jnci/78.1.171 ↗
42. 10.3109/07388551.2015.101595710.3109/07388551.2015.1015957 ↗
43. 10.1016/j.canlet.2010.05.02110.1016/j.canlet.2010.05.021 ↗
44. 10.1016/j.drup.2015.11.00410.1016/j.drup.2015.11.004 ↗
45. 10.3389/fphar.2018.0097110.3389/fphar.2018.00971 ↗
46. 10.1016/j.jconrel.2009.07.00910.1016/j.jconrel.2009.07.009 ↗
47. Crider B. P. · J. Biol. Chem. · 1994 · 269 · 1737910.1016/S0021-9258(17)32447-X ↗
48. 10.1073/pnas.85.21.797210.1073/pnas.85.21.7972 ↗
49. 10.1073/pnas.101161410710.1073/pnas.1011614107 ↗
50. 10.1016/j.chemphyslip.2016.11.00910.1016/j.chemphyslip.2016.11.009 ↗
51. 10.1016/s0168-3659(99)00114-510.1016/s0168-3659(99)00114-5 ↗
52. 10.1016/j.biomaterials.2013.10.01910.1016/j.biomaterials.2013.10.019 ↗
53. 10.1002/app.4209610.1002/app.42096 ↗
54. 10.1016/j.biomaterials.2010.11.06110.1016/j.biomaterials.2010.11.061 ↗
55. 10.1016/j.biomaterials.2016.10.03510.1016/j.biomaterials.2016.10.035 ↗
56. 10.1371/journal.pone.015814710.1371/journal.pone.0158147 ↗
57. 10.1021/acsami.8b0430110.1021/acsami.8b04301 ↗
58. 10.1002/wnan.145210.1002/wnan.1452 ↗
59. 10.1021/bc060077y10.1021/bc060077y ↗
60. 10.1021/mp400103f10.1021/mp400103f ↗
61. 10.1080/17425247.2016.118248510.1080/17425247.2016.1182485 ↗